What's going on with ellume's revenue?
Feb 02, 2021 · Ellume's agreement with the U.S. government could boost its revenue. As part of the contract, Ellume is supplying the U.S. government with 8.5 million of its home tests. This deal is set to boost ...
Is ellume listed on ASX?
May 10, 2021 · Ellume has 188 employees across 2 locations and $231.85 m in total funding,. See insights on Ellume including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Should you buy ellume stock before it goes public?
Dec 11, 2020 · The firm now trades on the Nasdaq under the ticker symbol SEER, and had a market cap of around $3.92 billion as of the close of the market on Thursday. Australian digital diagnostics company Ellume said this week it has received strategic investment from the Queensland State Government under the $50 million Essential Goods and Su pply Chain Program.
Is ellume Health publicly traded?
Jan 20, 2022 · Description Ellume Limited is a limited by shares, unlisted public company, Australian public company. This corporation was registered on 2010-02-01 and was issued with the 141767660 ACN. Its Australian Business Number is 13141767660. Since 2014-09-12, the company is headquartered in QLD, post code 4053.
How many shares does Ellume have?
As a private company, Ellume does have shares (84 million according to the AFR report). They are held by a small group of founders, employees and investors at Ellume though. The AFR tells us that Ellume chair and investor Paul Darrouzet holds a quarter of Ellume’s shares.
How much is Ellume contract?
That’s because ( as we reported at the time) Ellume has recently signed a massive US$250 million contract with the US government to supply 8.5 million testing kits. The deal also involves Ellume building a factory on US soil to meet demand.
Is Ellume a company?
Ellume has been a company on every investors’ lips over the past couple of months. The Brisbane-based medical company has been at the vanguard of Australia’s contribution to fighting the coronavirus pandemic. The company has pioneered an ‘at-home’ test for COVID-19.
Who is the CEO of Ellume?
Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with David Koch on Channel 7’s Sunrise program last week to discuss Ellume’s US$231.8 million contract with the U.S. Government to establish a U.S. manufacturing facility and deliver 8.5 million COVID-19 home tests across the U.S in the…
Where is Ellume located?
team to support the company’s rapid growth. Ellume establishes state-of-the-art diagnostic manufacturing facility in Frederick, Maryland, which is on track to begin limited operation in second half 2021; The facility was funded…
What is Ellume Lab?
Ellume is a Health Technology company that develops and manufactures connected real-time diagnostics for doctors and consumers. The Company develops ellume·lab, a versatile and convenient diagnostic device that complements a doctor’s decision making. The device allows for accurate and real-time near-patient testing in the convenience of a doctor’s office.
When will Ellume Health be built?
Under the agreement with the new Biden…. October 06, 2020.
What is the Ellume test?
The Ellume COVID-19 Home Test includes a set of instructions, nasal swab with child adapter, dropper, processing fluid, and analyzer. The Bluetooth®-enabled app walks users through step-by-step instructions to perform the test and receive a result.
What is Ellume's focus?
Ellume’s key focus is on the detection of common infectious diseases which affect the global population across all diagnostic settings; at-home, point-of-care and in-laboratory. Ellume’s suite of products differ from conventional diagnostics through performance, digital connectivity, actionability and simplicity.
Is Ellume a prescription drug?
The Ellume COVID-19 Home Test is the first non-prescription over-the-counter self-test authorized by the U.S. Food and Drug Administration.
Is Ellume a participant in RADX?
Ellume is a participant in the National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics (RADx) initiative and this agreement further extends the engagement between Ellume and the U.S. government in pandemic preparedness and response.
